Total Payments
$7,627
2024 Payments
$1,429
Companies
30
Transactions
93
Medicare Patients
5,718
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$7,612 (99.8%)
Education$14.99 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,612 | 90 | 99.8% |
| Education | $14.99 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $970.48 | 18 | $0 (2020) |
| IMBED BIOSCIENCES INC. | $779.46 | 11 | $0 (2023) |
| Lilly USA, LLC | $523.11 | 6 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $509.66 | 5 | $0 (2024) |
| PFIZER INC. | $380.76 | 4 | $0 (2020) |
| Allergan Inc. | $346.41 | 3 | $0 (2017) |
| Almirall LLC | $304.43 | 5 | $0 (2023) |
| Incyte Corporation | $288.82 | 3 | $0 (2024) |
| Dermavant Sciences, Inc. | $271.20 | 2 | $0 (2024) |
| Verrica Pharmaceuticals Inc. | $259.38 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,429 | 15 | Dermavant Sciences, Inc. ($146.48) |
| 2023 | $1,834 | 23 | IMBED BIOSCIENCES INC. ($779.46) |
| 2022 | $784.82 | 10 | Almirall LLC ($208.12) |
| 2021 | $308.06 | 3 | VYNE Pharmaceuticals Inc. ($183.19) |
| 2020 | $222.03 | 3 | PFIZER INC. ($122.40) |
| 2019 | $695.74 | 10 | AbbVie, Inc. ($242.12) |
| 2018 | $1,154 | 14 | AbbVie, Inc. ($522.21) |
| 2017 | $1,200 | 15 | Allergan Inc. ($346.41) |
All Payment Transactions
93 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $146.48 | General |
| Category: DERMATOLOGY | ||||||
| 11/12/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $111.58 | General |
| 10/08/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $124.84 | General |
| Category: Immunology | ||||||
| 09/10/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | TARGRETIN (Drug) | Food and Beverage | In-kind items and services | $113.88 | General |
| Category: Oncology | ||||||
| 08/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: IMMUNOLOGY | ||||||
| 06/28/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $37.94 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 06/11/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $129.62 | General |
| Category: Dermatology | ||||||
| 06/07/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $44.41 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 05/22/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $41.50 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 05/14/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $91.60 | General |
| Category: Monoclonal Antibody | ||||||
| 05/08/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 Marigen | Food and Beverage | Cash or cash equivalent | $119.16 | General |
| Category: Wound Care | ||||||
| 04/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $113.34 | General |
| Category: Immunology | ||||||
| 03/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $116.19 | General |
| Category: Immunology | ||||||
| 03/08/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $63.39 | General |
| Category: DERMATOLOGY | ||||||
| 01/12/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $50.12 | General |
| Category: DERMATOLOGY | ||||||
| 12/20/2023 | Ortho Dermatologics, a division of Bausch Health US, LLC | ARAZLO (Drug) | Food and Beverage | In-kind items and services | $122.95 | General |
| Category: Dermatology | ||||||
| 12/12/2023 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | Cash or cash equivalent | $113.21 | General |
| Category: Immunology | ||||||
| 12/01/2023 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $49.85 | General |
| Category: DERMATOLOGY | ||||||
| 11/10/2023 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $48.54 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2023 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $106.06 | General |
| Category: Dermatology | ||||||
| 09/22/2023 | Ortho Dermatologics, a division of Bausch Health US, LLC | TARGRETIN (Drug) | Food and Beverage | In-kind items and services | $113.68 | General |
| Category: Oncology | ||||||
| 09/15/2023 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $47.48 | General |
| Category: DERMATOLOGY | ||||||
| 08/08/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $118.50 | General |
| Category: IMMUNOLOGY | ||||||
| 07/24/2023 | BIOTISSUE HOLDINGS, INC. | NEOX (Medical Supply), CLARIX | Food and Beverage | In-kind items and services | $39.54 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 06/06/2023 | IMBED BIOSCIENCES INC. | — | Food and Beverage | Cash or cash equivalent | $70.86 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,382 | 1,861 | $792,366 | $373,368 |
| 2022 | 22 | 1,465 | 1,901 | $823,171 | $382,367 |
| 2021 | 23 | 1,418 | 1,893 | $748,372 | $363,758 |
| 2020 | 23 | 1,453 | 2,012 | $774,895 | $366,091 |
Total Patients
5,718
Total Services
7,667
Medicare Billing
$1.5M
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 303 | 390 | $394,335 | $192,894 | 48.9% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 130 | 179 | $101,851 | $59,620 | 58.5% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 33 | 35 | $32,200 | $16,597 | 51.5% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 65 | 68 | $47,260 | $12,973 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 149 | 195 | $24,338 | $12,445 | 51.1% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2023 | 15 | 15 | $19,545 | $11,870 | 60.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 141 | 141 | $28,200 | $11,325 | 40.2% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 11 | 11 | $16,148 | $8,160 | 50.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $14,500 | $7,131 | 49.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 95 | 134 | $14,338 | $5,737 | 40.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 49 | 72 | $14,328 | $4,920 | 34.3% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2023 | 19 | 19 | $15,295 | $3,816 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 39 | $8,775 | $3,723 | 42.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 78 | 99 | $9,900 | $3,489 | 35.2% |
| 12053 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 5.1-7.5 cm | Office | 2023 | 20 | 23 | $9,568 | $3,395 | 35.5% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 18 | 20 | $7,680 | $2,637 | 34.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 15 | 15 | $5,310 | $2,507 | 47.2% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 16 | 17 | $6,511 | $2,304 | 35.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 23 | 27 | $4,104 | $2,119 | 51.6% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 15 | $6,750 | $2,095 | 31.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 17 | 35 | $3,400 | $1,269 | 37.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 67 | 240 | $6,000 | $1,190 | 19.8% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Office | 2023 | 14 | 14 | $2,030 | $1,153 | 56.8% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 304 | 401 | $405,812 | $194,311 | 47.9% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 118 | 165 | $93,885 | $54,988 | 58.6% |
About Dr. Stephen Maberry, MD
Dr. Stephen Maberry, MD is a MOHS-Micrographic Surgery healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093754756.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Maberry, MD has received a total of $7,627 in payments from pharmaceutical and medical device companies, with $1,429 received in 2024. These payments were reported across 93 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($7,612).
As a Medicare-enrolled provider, Maberry has provided services to 5,718 Medicare beneficiaries, totaling 7,667 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Location Fort Worth, TX
- Active Since 06/06/2006
- Last Updated 09/09/2008
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1093754756
Products in Payments
- Humira (Biological) $418.52
- RHOFADE (Drug) $291.50
- OPZELURA (Drug) $288.82
- VTAMA (Drug) $271.20
- EUCRISA (Drug) $264.15
- YCANTH (Drug) $259.38
- SPEVIGO (Drug) $243.49
- DUPIXENT (Biological) $236.13
- TARGRETIN (Drug) $227.56
- Sotyktu (Drug) $226.26
- Klisyri (Drug) $207.96
- Ameluz (Drug) $204.65
- TALTZ (Drug) $173.45
- Acticlate (Drug) $144.02
- ZILXI (Drug) $133.61
- STELARA (Biological) $126.97
- INNOVAMATRIX AC (Device) $123.85
- ARAZLO (Drug) $122.95
- Erivedge (Biological) $120.72
- Xolair (Biological) $120.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.